MetaCap

Invesco S&P SmallCap Health Care ETF (PSCH)

NASDAQ: PSCHInvescoHealthETFUSD

54.11-0.9345 (-1.70%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

PSCH chart

Full chart

Key facts

Assets (AUM)
$178.51M
Holdings
10
Inception
Apr 7, 2010
Issuer
Invesco
Index tracked
—
Category
Health
52-week range
39.08 – 58.15
Volume / Avg
28.27K / 24.49K
Beta
—
Previous close
55.05

PSCH ETF today

The Invesco S&P SmallCap Health Care ETF (PSCH) is an exchange-traded fund from Invesco in the Health category. It charges an expense ratio of 0.29%, or $29.00 per year on a $10,000 investment, and manages $178.5 million in assets. Its largest holding is Glaukos Corp (GKOS) at 5.22% of assets, and the top 10 positions make up 34.9% of the portfolio out of 10 holdings.

PSCH launched on Apr 7, 2010.

Summary generated from market data by MetaCap's automated system. Methodology

PSCH top 10 holdings

PSCH holdings by weight
#HoldingWeight
1GKOSGlaukos Corp5.22%
2PTGXProtagonist Therapeutics Inc4.91%
3TGTXTG Therapeutics Inc4.26%
4ALKSAlkermes PLC3.66%
5LGNDLigand Pharmaceuticals Inc3.36%
6PTCTPTC Therapeutics Inc2.91%
7TFXTeleflex Inc2.85%
8MMSIMerit Medical Systems Inc2.77%
9RDNTRadNet Inc2.63%
10ITGRInteger Holdings Corp2.31%

Top 10 holdings: 34.9% of assets.

PSCH performance

1 week

-4.84%

1 month

+1.04%

PSCH price return, excluding dividends.

ETFs similar to PSCH

PSCH ETF FAQ

What is the PSCH price today?

PSCH last traded at $54.11 as of Nov 20, 4:00 PM EST, down 1.70% on the day.

What is PSCH's expense ratio?

PSCH has an expense ratio of 0.29%, which works out to about $29.00 per year for every $10,000 invested.

What are PSCH's top holdings?

PSCH's largest holdings are Glaukos Corp (5.22%), Protagonist Therapeutics Inc (4.91%), TG Therapeutics Inc (4.26%), Alkermes PLC (3.66%), Ligand Pharmaceuticals Inc (3.36%). The top 10 make up 34.9% of the fund.

How big is PSCH?

PSCH has about $178.5 million in assets under management spread across 10 holdings.

Explore